16/05/2024
Dasatinib Tablets 50 mg: Indications and Uses
Chronic Myeloid Leukemia (CML): Dasatinib Tablets 50 mg is prescribed for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase, accelerated phase, or blast phase. It is often used when other treatments, such as imatinib, are not effective or are not tolerated by the patient.
Acute Lymphoblastic Leukemia (ALL): Dasatinib is also indicated for the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who are resistant or intolerant to previous therapy.
Important Information:
Take Dasatinib exactly as prescribed by your healthcare provider.
Regular blood tests and follow-up appointments are necessary to monitor your response to the medication and manage any side effects.
Common side effects include low blood cell counts, fluid retention, diarrhea, headache, and rash. Contact your doctor if you experience severe or persistent side effects.
Consult Your Healthcare Provider:
Discuss your medical history, current medications, and any concerns with your healthcare provider to ensure Dasatinib is appropriate for your condition.
